TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
PMN

ProMIS Neurosciences Inc.

Healthcare · Biotechnology

9.40$ +0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement PMN
Line item 2013 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -94.2% -90.0% +394.3% -96.5% +244.7% +30.2% +965.8% -51.2% -100.0% – –
– -4.0% +76.0% +98.6% – – -32.8% +83.8% -99.7% +69,209.6% – –
– – – +293.0% -95.6% -1,357,591.3% – – – – – –
– -40.1% +81.7% +127.0% +72.7% -13.0% -32.8% +55.5% +324,947.4% -100.0% +34.9% +213.8%
– -24.0% +71.9% +39.8% +23.5% +29.3% -6.6% +35.5% +220,000.8% -99.9% -16.3% +9.7%
– +33.8% +142.3% +87.0% +55.9% -0.9% -66.5% +86.7% +504,553.2% -100.0% +99.1% +138.7%
– – – – – – – – – – – –
– – -33.8% -64.5% -100.0% – – – +67,657.3% -99.9% -61.9% -100.0%
– – – – – – – – – – – -1,529.3%
– +1,898,911.0% -31.6% -52.2% -2,866.3% – – +296,446,328.6% -1,381.3% – – –
– – – – – – – – – – – -1,529.3%
– – – – – – – – – – – -1,490.9%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?